What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?

Tiziano Tuccinardi
DOI: https://doi.org/10.1080/17460441.2021.1942836
2021-06-24
Expert Opinion on Drug Discovery
Abstract:The computer-aided drug design field is constituted by a wide range of different approaches that can be roughly classified as either ligand- or receptor-based techniques. In order to design and develop new active ligands, ligand-based approaches use the information derived from the properties of ligands with known activity against the target of interest, whereas the receptor-based techniques use the information obtained from the knowledge of the three-dimensional structure of the target and from the analysis of ligand–receptor interactions. With regards to the receptor-based techniques, one of the key steps of almost all approaches is represented by the estimation of the binding strength between the ligand and the receptor. Indeed, a proper evaluation of this interaction can be profitably used to design new ligands characterized by a tighter binding with the target of interest. Unfortunately, the main limitation of docking calculation resides in the estimation of the ligand–receptor interaction, which is usually evaluated through simple scoring functions. In particular, the scoring functions are used for both qualitative and quantitative studies: they are used for ranking different binding poses of the same ligand, thus providing its most reliable binding orientation, and they can also be used for comparing from an energetical point of view the interaction of different ligands with the same receptor, thus ranking the ligands according to the relative binding affinities. Although the available scoring functions are able to suggest the most reliable binding orientation for a ligand, their ability to predict ligand-receptor binding affinity and correctly rank different ligands on this basis is often not satisfactory enough. Among the different approaches that can be applied to evaluate the ligand–receptor interaction, the accurate measurement of binding free energy plays a very important role and, in this field, the most rigorous theoretical method is represented by free-energy perturbation (FEP), which estimates the difference in free energy between two states by slowly changing one state to another through a number of nonphysical intermediate states, performing extended sampling at each intermediate state [<span class="ref-lnk lazy-ref"><a href="#">1</a></span>]. Unfortunately, this method is extremely time consuming and therefore more approximate methods have been developed. In this context, the molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) developed by Kollman et al. [<span class="ref-lnk lazy-ref"><a href="#">2</a></span>,<span class="ref-lnk lazy-ref"><a href="#">3</a></span>] are among the most commonly used methods.
pharmacology & pharmacy
What problem does this paper attempt to address?